New study: can early palliative care help head and neck cancer patients suffer less?

NCT ID NCT07671573

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding palliative care early — alongside standard chemoradiotherapy — can improve symptoms and quality of life for people with advanced head and neck cancer that cannot be surgically removed. Researchers will compare two groups: one receiving standard treatment alone, and another receiving standard treatment plus regular palliative care consultations. The goal is to see if early support reduces pain, anxiety, and other burdens, and helps patients complete their cancer treatment more smoothly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

early palliative care (behavioral intervention)

What this could lead to

If it works, this could show that adding palliative care early helps patients manage symptoms better and complete cancer treatment with fewer interruptions.

What could go wrong

This is a small, early-stage trial with only 64 participants, so results may not apply to everyone. The benefit over standard care alone is not yet proven.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms head and neck squamous cell carcinoma neoplasm Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Medical Oncology (Portuguese Oncology Institute of Coimbra)-Portuguese Oncology Institute of Coimbra- Av. Bissaya Barreto 98, Celas, 3000-075 Coimbra

    Coimbra, Coimbra District, 3000-075, Portugal

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact